Short Summary
Uber Technologies filed a petition challenging Envosys's patent claims related to location tracking and dispatch systems. The petitioner asserts that the claims are obvious over various combinations of prior art, including vehicle dispatch and victim-offender tracking technologies. Uber contends these grounds are highly likely to prevail in the PTAB proceedings.
Detailed Summary
Uber Technologies, Inc., filed a petition challenging patent number 7199726 owned by Envosys, LLC. The petitioner asserts that several claims related to location tracking and dispatch systems are unpatentable under 35 U.S.C. § 103. Uber presents multiple grounds of obviousness, arguing that the claimed features—such as specifying geographic boundaries for notifications or determining relative proximity between units—are taught by combinations of prior art references like Suarez, Heedfeld, and Layson’757. The petition also notes related district court litigation involving Envosys against both Uber and Lyft.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Uber Technologies, Inc. vs Envosys, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Amazon.com Services LLCvsVB Assets, LLC
Amazon has filed an IPR petition seeking cancellation of all 19 claims of VB Assets’ ’025 patent covering voice‑driven song dedication, arguing the claims are obvious over existing speech‑interface and music‑dedication technologies.
Medtronic, Inc.vsMoskowitz Family LLC
Medtronic has filed an IPR petition challenging claim 43 of U.S. Patent 9,005,293, asserting that the claim is anticipated or obvious over prior‑art spinal‑implant references. The petition highlights alleged nondisclosure of key references during prosecution and deficiencies in the patent’s written description.
Imperative Care, Inc.vsInari Medical, Inc. et al.
Imperative Care successfully instituted an IPR against Inari Medical's 11,969,333 B2 patent covering intravascular clot removal. The Board found a reasonable likelihood of unpatentability based on obviousness over Laub, Garrison, and related references, and instituted review on all 36 challenged claims.
DraftKings Inc. et al.vsWinView IP Holdings, LLC
DraftKings has filed an IPR petition to invalidate 16 claims of a fantasy‑sports patent owned by WinView IP Holdings, asserting that the invention is already disclosed in earlier patents and publications.
Dr. Squatch, LLCvsThe Procter & Gamble Company
Dr. Squatch argues that the PTAB correctly rejected P&G’s attempts to reinterpret claim language and that the challenged deodorant stick claims are obvious over prior art. The petition also rebuts P&G’s RPI argument, maintaining that Dr. Squatch was the sole real party in interest.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.